Clinical Trial Update: Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

This update announces the completion and posting of results for a Phase 2 pilot study evaluating INNO-206 in advanced pancreatic ductal adenocarcinoma. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• INNO-206

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-06-06